Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Ke Y"'
Autor:
Li YK, Wu S, Wu YS, Zhang WH, Wang Y, Li YH, Kang Q, Huang SQ, Zheng K, Jiang GM, Wang QB, Liang YB, Li J, Lakang Y, Yang C, Wang JP, Kui X, Ke Y
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 11, Pp 1389-1402 (2024)
Yu-Kai Li,1,* Song Wu,2,* Yu-Shan Wu,3,* Wei-Hu Zhang,4,* Yan Wang,5,* Yue-Hua Li,1,* Qiang Kang,1,* Song-Quan Huang,1,* Kai Zheng,1 Gai-Ming Jiang,1 Qing-Bo Wang,1 Yu-Bo Liang,1 Jin Li,1 Yawhan Lakang,1 Chen Yang,1 Ji
Externí odkaz:
https://doaj.org/article/556a3af988db4082be9bab8be101724c
Publikováno v:
Cancer Management and Research, Vol Volume 14, Pp 317-325 (2022)
Yumin Ke,1,* Shuiling Zu,2,* Lijun Chen,3,* Meizhi Liu,4 Haijun Yang,5 Fuqiang Wang,5 Huanhuan Zheng,6 Fangjie He7,8 1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, People’s R
Externí odkaz:
https://doaj.org/article/535ab4168dd24d7a83654cab437938fc
Publikováno v:
OncoTargets and Therapy, Vol Volume 12, Pp 5897-5906 (2019)
Lingjuan He,1 Yinyan Li,1 Xin Huang,1 Hongqiang Cheng,2 Yuehai Ke,2 Linrun Wang11Department of Pharmacy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, Zhejiang, People’s Republic of China; 2Department of
Externí odkaz:
https://doaj.org/article/25a75d9db4b24307b2892b4f0a98f9c1
Publikováno v:
OncoTargets and Therapy, Vol Volume 9, Pp 6897-6907 (2016)
Jian-Hong Zhong,1,* Yang Ke,1,2,* Shao-Liang Zhu,1,* Lin Wang,2 Cheng-Piao Luo,3 Wen-Feng Gong,1 Xue-Mei You,1 Liang Ma,1 Bang-De Xiang,1 Le-Qun Li1 1Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nannin
Externí odkaz:
https://doaj.org/article/11846793666e4757ad61b691e689d4ac
Autor:
Chen Y, Li WX, Wu JH, Chen GH, Yang CM, Lu H, Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Hong RX, Jiang KK, Zhong YY, Zhang G, Tienchaiananda P, Oikawa M, Yuan ZY, Chen QJ
Publikováno v:
Breast Cancer: Targets and Therapy, Vol Volume 16, Pp 223-231 (2024)
Ying Chen,1,2,* Wen-Xia Li,1,2,* Jia-Hua Wu,1,2 Geng-Hang Chen,2 Chun-Min Yang,1,2 Hai Lu,1,2 Xi Wang,3 Shu-Sen Wang,4 Heng Huang,5 Li Cai,6 Li Zhao,7 Rou-Jun Peng,8 Ying Lin,9 Jun Tang,3 Jian Zeng,10 Le-Hong Zhang,11 Yong-Li Ke,12 Xian-Ming
Externí odkaz:
https://doaj.org/article/49c93cae53b24fb1863b44ec490bf852
Autor:
Chengcheng Fan, Xu Wang, Xiaoli Zheng, Yanan Sun, Ke Ye, Yue Jiang, Xiao Liu, Wencai Xu, Yang Liu, Yuanyuan Yang, Jinsong Liu, Qiong Jiang, Chunyu He, Xiaoyuan Wu, Xin Nie, Jingwei Zhang, Bo Tan, Wen Wang, Yougai Zhang, Zhuo Feng, Chengliang Yang, Yufei Lu, Hailong Liu, Xijuan Chen, Jing Xu, Fang Liu, Xuefeng Zheng, Jianhua Wang, Shang Wu, Guofu Chen, Yaowen Zhang, Linzhi Jin, Hong Ge
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Definitive concurrent chemoradiotherapy (dCCRT) is the gold standard for the treatment of locally advanced esophageal squamous cell carcinoma (ESCC). However, the potential benefits of consolidation chemotherapy after dCCRT in pat
Externí odkaz:
https://doaj.org/article/eab98104d16f4aac9490a07dabe0fc48
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 52, Iss , Pp 100996- (2024)
Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy, and its incidence has increased rapidly in recent years. The BRAF inhibitor vemurafenib is effective against BRAFV600E-positive PTC; however, acquired resistance to single age
Externí odkaz:
https://doaj.org/article/17f8d7b66f5943d1bfba677eca2baf69
Autor:
Run Hu, Jie Xu, Hongxiang Wang, Jiaguo Wang, Kai Lei, Xiaoping Zhao, Huizhi Zhang, Ke You, Zuojin Liu
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background The purpose of this propensity score matching (PSM) analysis was to compare the effects of preoperative transcatheter arterial chemoembolization (TACE) and non-TACE on the long-term survival of patients who undergo radical hepatec
Externí odkaz:
https://doaj.org/article/b4289b0085e6463fbba2f78dfa516f12
Autor:
Shengnan Yuan, Mingming Gao, Yizhou Wang, Yanjie Lan, Mengrou Li, Yuwei Du, Yue Li, Wen Ju, Yujin Huang, Ke Yuan, Lingyu Zeng
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Acute myeloid leukemia (AML) is a malignant hematologic disease caused by gene mutations and genomic rearrangements in hematologic progenitors. The PHF6 (PHD finger protein 6) gene is highly conserved and located on the X chromosome in human
Externí odkaz:
https://doaj.org/article/aff1112d003646a8b755e4717a6178f5
Autor:
Bing Wei, Jiadong Zhao, Jun Li, Junnan Feng, Manman Sun, Zhizhong Wang, Chao Shi, Ke Yang, Yue Qin, Jing Zhang, Jie Ma, Hui Dong
Publikováno v:
Cancer Medicine, Vol 12, Iss 23, Pp 21219-21228 (2023)
Abstract Backgroud Multiple studies have identified pathogenic germline variants in cancer susceptibility genes (CSGs) in Chinese lung cancer patients; however, accurate assessment of these variants' contributions to cancer predisposition is always h
Externí odkaz:
https://doaj.org/article/54fafa711d444c9292c8de419d3ab5cc